Corient Private Wealth’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485M | Buy |
623,661
+24,233
| +4% | +$18.8M | 0.51% | 34 |
|
|
2025
Q1 | $495M | Buy |
599,428
+23,225
| +4% | +$19.2M | 0.81% | 20 |
|
|
2024
Q4 | $443M | Sell |
576,203
-45,307
| -7% | -$34.8M | 0.73% | 22 |
|
|
2024
Q3 | $551M | Buy |
621,510
+16,578
| +3% | +$14.7M | 0.86% | 20 |
|
|
2024
Q2 | $548M | Sell |
604,932
-51,385
| -8% | -$46.6M | 0.96% | 17 |
|
|
2024
Q1 | $511M | Sell |
656,317
-19,171
| -3% | -$14.9M | 0.91% | 16 |
|
|
2023
Q4 | $394M | Buy |
675,488
+128,049
| +23% | +$74.6M | 0.72% | 27 |
|
|
2023
Q3 | $294M | Sell |
547,439
-41,793
| -7% | -$22.4M | 0.68% | 29 |
|
|
2023
Q2 | $276M | Buy |
589,232
+78,215
| +15% | +$36.7M | 0.64% | 31 |
|
|
2023
Q1 | $176M | Buy |
511,017
+172,733
| +51% | +$59.3M | 0.47% | 49 |
|
|
2022
Q4 | $124M | Buy |
+338,284
| New | +$124M | 0.45% | 56 |
|